Lipid Nanoparticles | CHOP Research Institute
 

Lipid Nanoparticles

Published on
Feb 24, 2025
A pre-clinical study sets the stage for medical advances: A gene therapy treatment approach for Fanconi anemia patients.

Dr. Alameh is focused on designing, synthetizing, optimizing, and understanding the structure-activity relationships of nucleic acid delivery systems and biomaterials, and their associated properties to improve the safety, reactogenicity, and potency of emerging mRNA therapeutics and vaccines.

E-mail:
alamehm [at] chop.edu